References
- Bodmeier R. Eur. J. Pharm. Biopharm. 1997; 43: 1
- Rácz I. Drug Formulation. John Wiley and Sons, New York 1989; 362
- Sousa J. J., Sousa A., Podczek F., Newton J. M. Int. J. Pharm. 1996; 144: 159
- Follonier N., Doelker E. S.T.P. Pharma Sci. 1992; 2: 141
- Marton S., Bihari E., Orban A., Greskovits D., Rácz I. Proceedings of the 1st World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, APGI/APV, Chatenay Malabry-Mainz. 1995; 357
- Newton J. M. S.T.P. Pharma Sci. 1990; 6: 396
- Sonaglio D., Bataille B., Ortigosa C., Jacob M. Int. J. Pharm. 1995; 115: 53
- Hasznos L., Langer I., Gyarmathy M. Drug Dev. Ind. Pharm. 1992; 18: 409
- Franz R. M., Browne J. E., Lewis A. R. Pharmaceutical Dosage Forms. Disperse Systems, H. A. Lieberman, M. M. Rieger, G. S. Banker. Marcel Dekker, New York 1988; 427
- Holm P. Pharm. Tech. Eur. 1996; 8: 38